Search engine for discovering works of Art, research articles, and books related to Art and Culture
Javascript must be enabled to continue!
Comparison of patient‐controlled and nurse‐controlled antiemetic therapy in patients receiving chemotherapy
View through CrossRef
AbstractThe purpose of this quasi‐experimental pilot study was to compare the effect of patient‐controlled (PCAE) and nurse administered (NCAE) antiemetic therapy for controlling chemotherapy‐induced nausea and vomiting in patients receiving moderate emetogenic chemotherapy. Twenty subjects were randomly assigned to either the PCAE group who received IV antiemetic medication via a patient‐controlled pump or the NCAE group who received antiemetic medication via nurse administered minibags. Nausea, vomiting, sedation, and drug consumption were measured. There was no difference in nausea scores between the two groups. Subjects in the PCAE group consumed significantly less medication than subjects in the NCAE group.
Title: Comparison of patient‐controlled and nurse‐controlled antiemetic therapy in patients receiving chemotherapy
Description:
AbstractThe purpose of this quasi‐experimental pilot study was to compare the effect of patient‐controlled (PCAE) and nurse administered (NCAE) antiemetic therapy for controlling chemotherapy‐induced nausea and vomiting in patients receiving moderate emetogenic chemotherapy.
Twenty subjects were randomly assigned to either the PCAE group who received IV antiemetic medication via a patient‐controlled pump or the NCAE group who received antiemetic medication via nurse administered minibags.
Nausea, vomiting, sedation, and drug consumption were measured.
There was no difference in nausea scores between the two groups.
Subjects in the PCAE group consumed significantly less medication than subjects in the NCAE group.
Related Results
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Microwave Ablation with or Without Chemotherapy in Management of Non-Small Cell Lung Cancer: A Systematic Review
Abstract
Introduction
Microwave ablation (MWA) has emerged as a minimally invasive treatment for patients with inoperable non-small cell lung cancer (NSCLC). However, whether it i...
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Small Cell Lung Cancer and Tarlatamab: A Meta-Analysis of Clinical Trials
Abstract
Introduction
Tarlatamab is a Delta-like ligand 3 (DLL3) -directed bispecific T-cell engager recently approved for use in patients with advanced small cell lung cancer (SCL...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
CHEMOTHERAPY INDUCED NAUSEA AND VOMITING;
Background: Ginger has long been used as an antiemetic herb in various systems for traditional medicine. However, lack of data on its utility in preventing chemotherapy induced vom...
Exploring the association between medical marijuana cardholder status and antiemetic overuse.
Exploring the association between medical marijuana cardholder status and antiemetic overuse.
e18812 Background: The conscientious prescribing of antiemetics by chemotherapy-induced nausea and vomiting (CINV) risk was highlighted in the American Society of Clinical Oncolog...
Renal Ewing Sarcoma: A Case Report and Literature Review
Renal Ewing Sarcoma: A Case Report and Literature Review
Abstract
Introduction
Primary renal Ewing sarcoma is an extremely rare and aggressive tumor, representing less than 1% of all renal tumors. This case report contributes valuable in...
Pembrolizumab and Sarcoma: A meta-analysis
Pembrolizumab and Sarcoma: A meta-analysis
Abstract
Introduction: Pembrolizumab is a monoclonal antibody that promotes antitumor immunity. This study presents a systematic review and meta-analysis of the efficacy and safety...
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract IA-08: Clinical advances in pancreas adenocarcinoma
Abstract
Pancreatic adenocarcinoma (PDAC) remains one of the most lethal cancers today and is expected to be the second cause of cancer death in the coming decade. M...